Judgment Day Has Arrived for SpaceX, With Up to $99 Billion in Selling Pressure Waiting in the Wings

SpaceX’s IPO proceeds $85.7B and initial valuation jump to nearly $3T have since reversed, with shares down 52% from their intraday peak. An accelerated lockup schedule means release-eligible insiders can sell beginning Aug. 4, with ~20% of early-release shares (~911.5M shares) potentially eligible in the first unlock window, implying up to ~$99B of potential selling pressure based on the July share price. With a notably low initial float (~4.9%) and unlock-driven free-float rising toward ~40% by Dec. 8, the article flags a likely multi-month overhang that could weigh on the stock through mid-December.

Analysis

SPCX is moving from narrative-led pricing to supply-led pricing. In very low-float situations, even a modest amount of insider distribution can reset the clearing price because the market has to re-finance a much larger free-float base; that usually compresses the multiple before fundamentals have time to matter. The immediate impact is lower, but the more important second-order effect is weaker sponsorship: institutions hate owning a stock whose next leg is gated by known unlocks, so every subsequent tranche can clear at a cheaper level.

The next 4-8 weeks look mechanically unfavorable: repeated unlock windows can cap upside, while post-IPO enthusiasm tends to decay once the first wave of passive buying has been absorbed. That said, this is not a one-way street—if the company prints a genuinely strong operating update, supply can be digested because scarcity plus accelerating growth can overpower distribution. The clean falsifier is price/volume behavior after the next unlock: if SPCX reclaims prior support and holds through another unlock with improving turnover, the overhang is less severe than the tape implies.

Contrarian view: the market may be overstating actual sell pressure by equating eligibility with execution. Many insiders optimize for taxes, diversification, and signaling, not immediate liquidation, so the headline theoretical supply can be far larger than what actually hits the tape. Even so, partial selling is enough to keep implied volatility elevated and delay multiple expansion into year-end; this is more a flow problem than a fundamentals problem, which argues for patience rather than chasing weakness.

Key Decisions for Investors

• Short SPCX on any relief rally into the next unlock window; use a tight risk limit above the prior post-earnings breakdown level, because the thesis is supply-driven and invalidates quickly if the stock can absorb a fresh tranche.
• If listed options are liquid, buy a 4-8 week put spread on SPCX centered around the next unlock date; the best payoff is from gradual bleed and vol expansion, not an outright crash.
• Pair trade: long NVDA / short SPCX for a 1-3 month horizon to isolate quality AI exposure versus flow-sensitive speculative equity; if the spread widens only on unlock headlines, take profits, because that would confirm the catalyst is technical rather than fundamental.
• Do not size aggressively until actual insider sale disclosures are visible; if reported selling is materially below the theoretical unlock capacity, cover shorts early because the market may have already priced the worst-case supply scenario.